1
|
Grezenko H, Rodoshi ZN, Mimms CS, Ahmed M, Sabani A, Hlaing MS, Batu BJ, Hundesa MI, Ayalew BD, Shehryar A, Rehman A, Hassan A. From Alzheimer's Disease to Anxiety, Epilepsy to Schizophrenia: A Comprehensive Dive Into Neuro-Psychiatric Disorders. Cureus 2024; 16:e58776. [PMID: 38784315 PMCID: PMC11112393 DOI: 10.7759/cureus.58776] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/19/2024] [Indexed: 05/25/2024] Open
Abstract
This comprehensive narrative review endeavors to dissect the intricate web of neuropsychiatric disorders that significantly impact cognition, emotion regulation, behavior, and mental health. With a keen focus on Alzheimer's disease (AD), anxiety disorders, epilepsy, schizophrenia, and autism spectrum disorder (ASD), this article delves into their underlying mechanisms, clinical presentations, diagnostic challenges, and therapeutic interventions. Highlighting the considerable disability and societal costs that these conditions impose, it reflects on the over six million individuals grappling with Alzheimer's, the 19 million American adults living with anxiety disorders, the three million with epilepsy, and the global reach of schizophrenia affecting approximately 20 million people. Furthermore, it examines the emerging landscape of ASD, noting the escalating diagnosis rates and the pressing need for innovative treatments and equitable healthcare access. Through a detailed exploration of current research, technological innovations, and the promise of personalized medicine, this review aims to illuminate the complexities of these conditions, advocate for early intervention strategies, and call for a unified approach to tackling the multifaceted challenges they present. The ultimate goal is to inform and inspire healthcare professionals, researchers, and policymakers to foster advancements that improve outcomes and quality of life for individuals affected by these profound neuropsychiatric disorders, steering towards a future where these conditions are no longer insurmountable.
Collapse
Affiliation(s)
- Han Grezenko
- Medicine and Surgery, Guangxi Medical University, Nanning, CHN
- Translational Neuroscience, Barrow Neurological Institute, Phoenix, USA
| | | | - Ciara S Mimms
- Medicine, St. George's University, St. George's, USA
| | - Muhammad Ahmed
- Psychiatry and Behavioral Sciences, Dow University of Health Sciences, Karachi, PAK
| | - Astrit Sabani
- Medicine, St. George's University, St. George's, USA
| | - May Su Hlaing
- Geriatrics, United Lincolnshire Hospitals NHS Trust, Boston, GBR
| | - Biniyam J Batu
- General Practice, St. Paul's Hospital Millennium Medical College, Addis Ababa, ETH
| | - Muhidin I Hundesa
- Medical Services, Federal Democratic Republic of Ethiopia Ministry of Health, Addis Ababa, ETH
| | - Biruk D Ayalew
- Internal Medicine, St. Paul's Hospital Millennium Medical College, Addis Ababa, ETH
| | | | | | | |
Collapse
|
2
|
Semennov IV, Pyatoikina AS, Zagryazhskaya YS, Rukavishnikov GV, Kas’yanov ED, Zhilyaeva TV, Blagonravova AS, Mazo GE. Biochemical Markers of Folate Metabolism Disorders in Schizophrenia in the Russian Population. NEUROCHEM J+ 2021. [DOI: 10.1134/s1819712421010116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|